The global genital warts (condyloma acuminatum) market is expected to be worth US$ 1.87 billion in 2023, rising to US$ 3 billion by 2033 at a CAGR of 4.84%. The dynamics of the genital warts market are expected to change in the coming years as new drugs are introduced. Drugs for genital warts are being developed by key players such as Tamir Biotechnology (Orgenesis), Verrica Pharmaceuticals, Novan Inc., and others. Furthermore, successful and well-communicated vaccination programmes have increased public awareness of vaccines and their benefits, leading to increased vaccine uptake. Furthermore, increased vaccination coverage has been linked to a decrease in the occurrence of genital warts.
FMI, in its business report, elaborates the historical and current scenario of the global Genital Warts (Condyloma Acuminatum) Market in terms of production, consumption, volume, and value. The report scrutinizes the market into various segments, regions and players on the basis of demand pattern and growth prospects.
Genital Warts (Condyloma Acuminatum) Market: Segmentation
Valuable information covered in the FMI’s Genital Warts (Condyloma Acuminatum) market report has been segregated into key segments and sub-segments.
Genital Warts Market by Treatment:
- Chemical Treatment
- Ablative Treatment
- Preventive Treatment
- Other Treatments
Genital Warts Market by Distribution Channel:
- Hospital Pharmacies
- Retail pharmacies
- Online Pharmacies
Browse More@ https://www.futuremarketinsights.com/reports/genital-warts-condyloma-acuminatum-market
Genital Warts (Condyloma Acuminatum) Market: Competition Analysis
The FMI’s study presents a comprehensive analysis of global, regional, and country-level players active in the Genital Warts (Condyloma Acuminatum) market. Competitive information detailed in the Genital Warts (Condyloma Acuminatum) market report has been based on innovative product launches, distribution channels, local networks, industrial penetration, production methods, and revenue generation of each market player. Furthermore, growth strategies and mergers & acquisitions (M&A) activities associated with the players are enclosed in the Genital Warts (Condyloma Acuminatum) market report.
Key players covered in the report include:
- Verrica Pharmaceuticals
- Tamir Biotechnology
- Novan Inc.
- Medicis Pharmaceuticals
- Aresus Pharma
- AbbVie Inc.
- Sanofi S.A.
- Perrigo Company PLC
- Glenmark Pharmaceuticals
